A clinical study to assess moisture kinetics, brightness and anti-ageing related benefits, safety, efficacy and in-use tolerability of Day Cream, Night Cream, Skin Serum and Anti-Aging Cream - Nil

Dabur India Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年1月22日

试验速览

暂无简介。

•1) Age: 30 - 55 above (both inclusive) old at the time of consent.
•2) Sex: Healthy non-pregnant/non-lactating females.
•3) Females of childbearing potential must have a self-reported negative urine pregnancy test.
•4) Subjects are generally in good general health as determined from recent medical history.
•5)Subjects forearm must be free of cuts, tattoos, scratches, abrasions, scars, uneven skin tone, sunburn, excessive tan, excessive hair or open wounds on or near the test sites.
•6) Subjects with mild to moderate age spots, sun spots, dark spots.
•7) The subject is willing and able to follow the study directions, participate in the study, returning for all specified visits.
•8) The subject must be able to understand and provide written informed consent to participate in the study.

•1) Subject with known allergy or sensitization to product ingredients.
•2) Subjects with very severe persistent spots.
•3) The subject has clinically significant skin disease, which may contraindicate participation, including psoriasis, eczema, Skin cancer or other skin pathology.
•4)The subject has skin irritation, open wounds, cuts, abrasions, irritation symptoms or any dermatological condition on the face that can interfere with the reading.
•5)Be wearing any facial makeup, including false eyelashes, on the day of the study visit
•6)Subject participation in the study involving the only one application of a personal care product such as lotion or cleansing product to the test area with no invasive procedure within the four weeks prior to enrolment.
•7)Medication which may affect skin response and/or past medical history.
•8)Topical drugs used at the application site.
•9)An individual who has a medical condition or is taking or has taken a medication which, in the Investigator’s judgment, makes the subject ineligible or places the subject at undue risk.
•10)Subjects who have been treated with systemic retinoids or steroids within the past month prior to entry to the study.
•11)Subjects who have been treated with topical steroids, retinoids or other topical drugs within 2 weeks prior to entry to the study.
•12)Participation in other clinical studies simultaneously.

发起方